Skip to content

PTHS PTHS Total Equity

Total Equity at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$21.64M-24.5%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$30.83M+43.1%
Opko Health logo
Opko HealthOPK
$1.2B-8.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$205.8M+402%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$290.59M+75.1%
HRO
HarrowHROW
$28.71M-49.1%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's total equity?
PTHS (PTHS) reported total equity of $35.1M in Q1 2026.
How has PTHS's total equity changed year-over-year?
PTHS's total equity increased by 936.6% year-over-year, from -$4.2M to $35.1M.
What is the long-term trend for PTHS's total equity?
Over 4 years (2021 to 2025), PTHS's total equity has grown at a 80.3% compound annual growth rate (CAGR), from -$3.68M to $38.88M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.